biuro@scopefluidics.com +48 22 376 21 14

<img src="https://scopefluidics.com/wp-content/uploads/scope-logo.svg" alt="scope-logo" width="285" height="85" title="scope-logo" />

About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact

biuro@scopefluidics.com +48 22 376 21 14

<img src="https://scopefluidics.com/wp-content/uploads/scope-logo.svg" alt="scope-logo" width="285" height="85" title="scope-logo" />

About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact

biuro@scopefluidics.com +48 22 376 21 14

RAPORT ESPI 37/2019 | 15-12-2019 | Informacja o transakcji otrzymana w trybie art. 19 MAR

Previous PostRAPORT ESPI 36/2019 | 15-12-2019 | Informacja o transakcji otrzymana w trybie art. 19 MARNext PostRAPORT ESPI 38/2019 | 16-12-2019 | Zawiadomienie o zmianie stanu posiadania akcji Spółki

0Shares

Related Posts

Most Influencing Person title for prof. Piotr Garstecki

Prof. Piotr Garstecki with the title of Health Policy Authority

Prof. Piotr Garstecki on the cover of Forbes magazine!

Contact Us

Tel. +48 22 376 21 14
E-mail: biuro@scopefluidics.com

Adress

Ogrodowa 58 Street
9th floor
00-876 Warsaw

KRS: 0000668408

NIP: 527-264-59-89

REGON: 142-754-170

LEI: 259400EUNFX4E2BEHU15

The company is registered in the District Court for the capital city of Warsaw in Warsaw, 14th Commercial Division of the National Court Register.

Share capital: 272 593,00 zł,

Bank Account Number: 03 2490 0005 0000 4520 3046 2136

Terms of use

Cookies Policy

Scope Fluidics 2022 ® All rights reserved